CytoSorbents Corporation (CTSO)

[biotech48]

Murph, "CytoSorbents and its technology has garnered more than $26 million in support from the U.S. government. DARPA, or the Defense Advanced Research Projects Agency, as part of its “Dialysis-Like Therapeutics” program to treat sepsis, awarded CytoSorbents a $3.8 million five year contract to develop cytokine and toxin binders for the program. CytoSorbents collaborated with groups such as Battelle Laboratories, Harvard’s Wyss Institute, NxStage Medical (recently acquired by Fresenius Medical Care), Massachusetts Institute of Technology, and others in this program."

https://cytosorbents.com/about/about-us/